AstraZeneca Gets Delhi HC Relief in Rs 151 Crore NPPA Overcharging Case

Written By : Susmita Roy Published On 2026-11-03T19:15:55+05:30 | Updated On 4 Nov 2026 12:14 AM IST

AstraZeneca Gets CDSCO Nod to Market Enhertu for New Breast Cancer Indication

New Delhi: The Delhi High Court has directed the National Pharmaceutical Pricing Authority (NPPA) not to take coercive steps against AstraZeneca Pharma India Limited until January 11, 2027, in a dispute concerning approximately Rs 151.20 crore in alleged overcharging and interest relating to Symbicort Turbuhaler 160/4.5 (Inhaler).

The dispute follows a show cause notice dated September 11, 2025. The company subsequently received an NPPA notice on July 29, 2026, and a further reminder alleging overcharging in connection with the inhaler under the DPCO, 2013.

The company challenged the demand before the Delhi High Court. According to its latest disclosure, the court has directed that no coercive steps be taken by NPPA in the matter until the next hearing, listed for January 11, 2027.

Also Read:Delhi HC Seeks Urgent Report on Doctors' Qualifications in Fortis Shalimar Bagh Negligence Case

The company received the High Court’s order on October 30, 2026.

Explaining the financial implications in Annexure A to the filing, AstraZeneca stated that the order prevents NPPA from taking coercive steps until the next hearing to recover approximately ₹151,19,66,035. This amount comprises the alleged overcharged sum and interest calculated up to October 30, 2026.

The disclosed direction provides protection against coercive recovery until the next hearing; it does not record a final determination of the overcharging allegations or cancellation of the demand.

Also Read:NPPA Lists Revised MRPs for 643 Cancer Drug Entries, Palbopro MRP Falls 93%, Keytruda, Tagrisso Rates Unchanged

nppaastrazenecaastrazeneca pharma indiasymbicortsymbicort turbuhalarDelhi High Courtdrug overcharging

Medical Survey

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Print Article